Integrated Oil Russia Update: Shell Exits, Total Sticks
Exxon's answer is likely coming soon.
Exxon's answer is likely coming soon.
Following Shell’s (SHEL) announcement of a complete exit from Russia (see Feb 28. note), TotalEnergies released a statement condemning Russia’s military aggression against Ukraine but did not announce intentions to exit the country. Instead, it stated it merely would no longer provide capital for new projects. While things could change and greater sanctions force its hand or make it untenable to stay, Total (TTE) appears to be willing to ride out the storm for now. Its Russian assets include 20% of Yamal LNG, 21.64% of Arctic LNG 2, a 49% interest in ZAO Terneftegas operator of Termokarstovoye onshore gas field, and a 19.4% interest in Novatek.
As we’ve written, Total’s exposure is more complicated than peers. Nearly all of BP’s (BP) interests in Russia are held in its Rosneft stake and Shell’s were largely in two assets, but Total’s relationship is more involved as it holds direct interests in projects like Yamal LNG and Artic 2 LNG in addition to an indirect interest in the projects through its Novatek stake. As such, simply divesting its Novatek stake would not rid it of its Russia exposure. Total’s exposure is more meaningful as well, with Russia accounting for about 5% of Total’s oil production and 30% of its natural gas production.
Rystad places the value of Total’s Russian assets, outside of Novatek, at about $10 billion. The value of its Novatek stake has fallen sharply from $13.1 billion at the beginning of the year to an estimated $1.3 billion currently, based on ruble declines and London shares trading. As Total accounts for Novatek using the equity method, our fair value estimate is not impacted at this point by the share price declines. Furthermore, assuming no value for all Russian assets, we estimate would reduce our fair value estimate by 10% but largely be offset by recent increases in oil prices.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days. |
Allen Good does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.